Best I3 Podcasts (2025)

Last Chance: Multiple Myeloma Task Force PodcastDon't miss your final opportunity to listen to this CME/NCPD-accredited podcast on Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Healthcare Disparities in Relapsed/Refractory Multiple Myeloma. Last chance to listen and claim credit is September 10, 2025.Hear from T…

1
Latest Content - Car and Driver: When It Comes to Charging, Some EVs Are More Resourceful Than Others 0:15

Play Pause

31m ago0:15

0:15

1
Latest Content - Car and Driver: 1997 Plymouth Prowler Originally Owned by Bob Lutz Is For Sale on Bring a Trailer 0:13

14m ago0:13

0:13

1
Latest Content - Car and Driver: View Photos of the 2002 Full-Size 4x4 Pickup Comparison Test 0:20

23m ago0:20

0:20

1
Latest Content - Car and Driver: 2002 Full-Size 4x4 Pickup Comparison Test: Chevy vs. Dodge vs. Ford vs. Toyota 0:26

23m ago0:26

0:26

1
iPhone in Canada: Apple Hit With Lawsuit Over Using Pirated Books to Train AI 0:31

19m ago0:31

0:31

1
Latest Content - Car and Driver: Is the New Honda Prelude Exciting or Disappointing? We Have Opinions 0:14

19m ago0:14

0:14

1
iPhone in Canada: PM Carney Pauses Trudeau’s 2026 EV Sales Mandate, Dealers React 0:38

19m ago0:38

0:38

1
Latest Content - Car and Driver: ICE Raids Hyundai's Georgia Plant to Enforce Foreign Worker Laws 0:13

19m ago0:13

0:13

1
Latest Content - Car and Driver: 2026 Toyota Highlander Starts $5000 Higher, FWD Models Dropped 0:18

14m ago0:18

0:18

1
iPhone in Canada: Telus CEO Donates $2.2M Collection to Vancouver Art Gallery 0:38

1h ago0:38

0:38

1
iPhone in Canada: OpenAI Unveils New Jobs Platform to Certify AI Workers 0:22

29m ago0:22

0:22

1
iPhone in Canada: Wealthsimple Confirms Security Breach—Here’s What Happened 0:37

30m ago0:37

0:37

1
iPhone in Canada: EU Slams Google with Massive $3.5 Billion Fine 0:23

30m ago0:23

0:23

1
iPhone in Canada: How to Watch NFL Games in Canada: Live TV and Streaming Guide 0:33

30m ago0:33

0:33

1
iPhone in Canada: What to Expect at Apple’s September iPhone 17 Event 0:31

29m ago0:31

0:31

1
iPhone in Canada: Telus and Koodo Hike Connection Fee to $80, Matching Rogers 0:33

29m ago0:33

0:33

1
iPhone in Canada: Here’s What Apple CEO Tim Cook Said to Trump at the White House Dinner 0:33

29m ago0:33

0:33

1
Latest Content - Car and Driver: 2026 Honda Prelude vs. the Toyota Prius: Unlikely Competitors? 0:15

11m ago0:15

0:15

1
Latest Content - Car and Driver: Porsche EVs Can Now Access Tesla's Vast Supercharger Network 0:18

10m ago0:18

0:18

1
Latest Content - Car and Driver: View Interior Photos of the 2025 Porsche Taycan Turbo S Cross Turismo 0:14

16m ago0:14

0:14

1
Latest Content - Car and Driver: 2025 Porsche Taycan Turbo S Cross Turismo Test: The Ultimate Longroof 0:16

16m ago0:16

0:16

1
Latest Content - Car and Driver: View Exterior Photos of the 2025 Porsche Taycan Turbo S Cross Turismo 0:14

16m ago0:14

0:14

1
iPhone in Canada: Developers Opting for Game-Key Card Due to Nintendo Switch 2 Storage Speeds 0:21

1h ago0:21

0:21

1
Latest Content - Car and Driver: 2026 BMW iX3 0:07

2h ago0:07

0:07

1
iPhone in Canada: Legion Go 2 to Launch in October, Here are the Official Specs 0:19

2h ago0:19

0:19

1
Latest Content - Car and Driver: View Exterior Photos of the 2026 BMW iX3 0:13

16m ago0:13

0:13

1
Latest Content - Car and Driver: View Interior Photos of the 2026 BMW iX3 0:13

16m ago0:13

0:13

1
Latest Content - Car and Driver: 2026 BMW iX3 Debuts with Sharp Styling and a 43-Inch Windshield Display 0:16

16m ago0:16

0:16

1
Latest Content - Car and Driver: 2027 Mercedes-Benz GLC EV Interior Shown with Huge 39-Inch Screen 0:17

2h ago0:17

0:17

1
118: National Reconstruction Fund's Mary Manning – Supporting Australian Manufacturing, Quantum Diamonds and Cyber Security 46:50

4d ago46:50

46:50

In this episode of the [i3] podcast, “Conversations with Institutional Investors”, we speak with Mary Manning, Chief Investment Officer of the National Reconstruction Fund Corporation, a recently established $15 billion fund that has been set up to promote the manufacturing industry in Australia. We speak with Mary about the investment objectives a…

1
117: Geopolitics with Alan Dupont – Tech wars, Geoeconomics and the Mag 7 43:35

18d ago43:35

43:35

In this episode, I'm speaking with Dr Alan Dupont, who is the founder and CEO of Cognoscenti Group. Alan is a highly respected geopolitical strategist and has advised a wide range of governmental and commercial organisations, including the Northern Territory Government, Asia Society, the Australian Strategic Policy Institute and Outcomes Australia.…

1
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2 27:10

1M ago27:10

27:10

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence o…

1
Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1 25:39

1M ago25:39

25:39

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.In module 1, Dr. Janjigian provides an in-depth overview of the latest biomarkers—such as HER2, PD-L1, MMR/MSI-H, CLDN18.2, and FGFR2—and their role in guiding treatment decisions for esophagog…

1
Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC 12:36

1M ago12:36

12:36

Genetic testing and counseling are crucial components of precision medicine in cancer care, enabling clinicians to deliver the right care, to the right patient, at the right time. i3 Health’s educational activity, Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, provides a comprehensive foundation for incorporatin…

1
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 2 24:28

1M ago24:28

24:28

i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC).In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Fa…

1
Additional Advances in HER2-Mutated NSCLC With Julia Kathleen Rotow, MD + Activity Module 1 24:32

1M ago24:32

24:32

i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC).In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Fa…

1
EXPIRING SOON! Optimizing Cancer Screening With MCED Technologies - Module 3: Implementing MCED Testing in Clinical Practice Through Case Studies 23:43

1M ago23:43

23:43

Hurry—listen to Module 3 and claim your CME credit by August 19!Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. In this final module, Dr. Charles Vega, Clinical Professor of Family Medicine at the University of California, Irvin…

1
EXPIRING SOON! Optimizing Cancer Screening With MCED Technologies - Module 2: Clinical Evidence for MCED Testing 20:13

1M ago20:13

20:13

Time is running out—listen to Module 2 and claim your CME credit by August 19!Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. In Module 2, Dr. Charles Vega takes you deeper into the cutting-edge world of multicancer early detect…

1
EXPIRING SOON! Optimizing Cancer Screening With MCED Technologies - Module 1: Science Behind Cancer Screening 20:16

1M ago20:16

20:16

Don’t miss your chance—listen to Module 1 and claim your CME credit by August 19! Join Dr. Charles Vega, a distinguished Clinical Professor of Family Medicine at the University of California, Irvine, as he explores the cutting-edge field of multicancer early detection (MCED). In this engaging session, Dr. Vega delves into the scientific foundations…

1
116: Igneo Infrastructure Partners' Danny Latham – Infrastructure 2.0, Waste to Energy and Transition Assets 1:00:52

1M ago1:00:52

1:00:52

In this episode of the [i3] podcast, Conversations with Institutional Investors, we speak with Danny Latham, Partner and Head of Australia and New Zealand for Igneo Infrastructure Partners. We discuss the evolution of infrastructure assets, termed "Infrastructure 2.0," which includes renewable energy, digitalisation, and waste management. Danny hig…

1
Solving the Ulcerative Colitis Puzzle: How to Navigate the Treatment Journey 8:55

1M ago8:55

8:55

For patients with ulcerative colitis, newly developed therapies and tailored treatment strategies have allowed for a more personalized approach to achieving disease control and remission. In this special podcast interview, Dr. Benjamin Cohen, Co-Section Head and Clinical Director of Inflammatory Bowel Diseases at the Cleveland Clinic, offers a behi…

1
Multicancer Early Detection: A Fellow’s Perspective With Waqas Haque, MD, MPH 14:59

1M ago14:59

14:59

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Waqas Haque, a Hematology/Oncology Fellow at the University of Chicago, recently shared his perspectives on i3 Health’s CME activity, Optimizing Cancer Screening with MCED Technologies: From Science to Practical…

1
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD 37:31

2M ago37:31

37:31

As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies remains at the forefront of patient care. Recently, Dr. Richard Riedel of Duke Cancer Institute and Dr. Candace Haddox of Dana-Farber Cancer Institute co-chaired i3 Health’s DDLPS Task Force …

1
Unmasking Hereditary ATTR-CM: A Webinar Preview With Mathew Maurer, MD 8:44

2M ago8:44

8:44

Join i3 Health for a special live webinar, Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy, being held on Wednesday, July 30 at 5:00 pm ET. In this exclusive event, Dr. Mathew Maurer, the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, will share his ex…

1
115: Gain Line Analytics' Ben Darwin – Performance Analytics, Team Cohesion and The Wallabies 1:07:44

2M ago1:07:44

1:07:44

Ben Darwin is the Co-founder and General Manager of Corporate at Gain Line Analytics and in this episode we're going to take a look at what makes teams successful and stay successful. Ben is a former Wallaby player, having played 28 test matches for Australia. He's a former coach and a performance analyst, having worked with a number of rugby teams…

1
Exploring the Evolution of Neuroendocrine Tumor Diagnostics and Therapeutics: A Webinar Preview With Aman Chauhan, MD 8:24

2M ago8:24

8:24

Join i3 Health for a special live webinar, Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, being held on Thursday, July 17th at 12:00 pm Eastern and on Tuesday, August 5th at 3:00 pm Eastern. In this exclusive event, Dr. Aman Chauhan, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester …

1
114: Bellmont Securities' Michael Block – The Michael Block Roadmap to Investing 59:27

2M ago59:27

59:27

Michael Block is Chief Investment Officer of Bellmont Securities and Adjunct Industry Professor at the University of Technology Sydney (UTS), where he helped establish the UTS Anchor Fund. The UTS Anchor Fund is a live investment portfolio managed by students to give them hands on experience with managing portfolios. In this episode, we take a look…

1
Challenges and Innovations in Biliary Tract Cancer: A Multidisciplinary Task Force Perspective 27:45

3M ago27:45

27:45

Biliary tract cancer (BTC) presents a complex puzzle for the interprofessional healthcare team. With its diverse subtypes and unique molecular features, diagnosis and treatment require a personalized approach. Stay ahead of the curve with insights from leading experts, Dr. Anjana Pillai and Dr. Rachna Shroff, as they explore the latest genomic rese…